Dr Leylah Drusbosky
Associate Editor: Leylah Drusbosky
Dr. Drusbosky is a Research Assistant Professor in the College of Medicine and the Scientific Director of iCare for Cancer Patients, a precision oncology program at the University of Florida. Her research interests combine cancer genetics with computational biology to illuminate aberrant signaling pathways within hematological malignancies, and identify novel combinations of therapeutics to target each patient’s unique cancer mutanome. Dr. Drusbosky is developing assays to non-invasively monitor patient’s response to therapy, and detect relapsing disease before clinically indicated.
Additional research interests include the protective bone marrow microenvironment as related to leukemia and myelodysplastic syndromes, xenograft models of myeloid malignancies, biomarker and drug discovery, and gene expression profiling of tumor cells.